KMT2A and acute lymphoblastic leukemia: Several other studies have demonstrated notable heterogeneity in patients with other types of leukemia, including chronic myelomonocytic leukemia, KMT2A-rearranged infant acute lymphoblastic leukemia (ALL), and t (8;21) AML (Jiang L et al.